Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.21.1
Stock-Based Compensation (Tables)
 3 Months Ended
Mar. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of summary of stock option activity
The following is a summary of option activities under the Company’s 2014 Plan for the three months ended March 31, 2021:
Number of
Shares		 Weighted
Average
Exercise Price		 Weighted
Average
Remaining
Contractual
Term (Years)
Outstanding, December 31, 2020 22,050,000  $ 0.06  9.52
Granted —  — 
Cancelled (360,000) 0.05 
Forfeited (40,000) 0.05 
Outstanding, March 31, 2021 21,650,000  $ 0.06  9.27
Exercisable, March 31, 2021 5,705,000  $ 0.11  8.92
Vested and expected to vest, March 31, 2021 21,650,000  $ 0.06  9.27
Schedule of RSA activity
The following is a summary of restricted stock activity outside of the Company’s 2014 Plan during the three months ended March 31, 2021:
Number of
Shares		 Weighted
Average
Grant
Date Fair
Value
Unvested, December 31, 2020 —  $ — 
Granted 1,200,000  0.08 
Released (600,000) 0.08 
Unvested, March 31, 2021 600,000  $ 0.08 
Schedule of stock-based compensation expense Stock-based compensation expense (including compensation expense for restricted stock awards discussed above) was as follows:
Three Months Ended March 31,
2021 2020
Research and development $ 74,429  $ — 
General and administrative 72,151  64,142 
$ 146,580  $ 64,142